A subset of trademark law, “trade dress,” provides the legal basis for drug manufacturers' exclusivity claims on the size, shape, and color of pills. The authors discuss the potential adverse effects of trade-dress protection and suggest strategies to address this problem.
No takes yet. Share an insight, caveat, or question.
Greene et al. (2011) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: